Lv7
5000 积分 2023-08-09 加入
Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activation
9天前
已完结
Significance of TRAIL/Apo-2 ligand and its death receptors in apoptosis and necroptosis signalling: Implications for cancer-targeted therapeutics
9天前
已关闭
A guide to cell death pathways
9天前
已完结
Compact clustering of highly oligomerized anti-DR5 nanobodies effectively drives apoptotic cancer cell death, significantly suppressing tumor growth
9天前
已关闭
Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy
9天前
已完结
TRIAL-based combination therapies in cancers
9天前
已关闭
Multivalent assembly of nucleolin-targeted F3 peptide potentiates TRAIL's tumor penetration and antitumor effects
10天前
已关闭
Aponermin: First Approval
10天前
已完结
Tertiary lymphoid structures in cancer
10天前
已完结
Linker Design for The Antibody Drug Conjugates: A Comprehensive Review
11天前
已完结
皖公网安备34019202002308
